Alcidion GroupASX:ALC -1.01% Graham Number is A$0.01 as of Dec. 2025, which is 100% below its 10-year median of 10.50. The stock has 4 warning signs investors should review. Among 369 Healthcare Providers & Services companies, Alcidion Group ranks worse than 271002.44% on this metric.
Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.
As of today (2026-07-11), the stock price of Alcidion Group is A$0.098. Alcidion Group's graham number for the quarter that ended in Dec. 2025 was A$0.01. Therefore, Alcidion Group's Price to Graham Number ratio for today is 11.93.
The historical rank and industry rank for Alcidion Group's Graham Number or its related term are showing as below:
During the past 13 years, the highest Price to Graham Number ratio of Alcidion Group was 10.50. The lowest was 10.00. And the median was 10.50.
ASX:ALC's Price-to-Graham-Number is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.69 * Ranked among companies with meaningful Price-to-Graham-Number only.
Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.
Alcidion Group (ASX:ALC) Graham Number Explanation
Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:
Current price should not be more than 15 times average earnings of the past three years.
Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)
Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.
In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.
Alcidion Group's Price to Graham number Ratio for today is calculated as
Price to Graham number
=
Share Price (Today)
/
Graham number (Q: Dec. 2025 )
=
0.098
/
0.01
=
11.93
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Please keep these in mind:
1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.
Alcidion Group Graham Number Related Terms
Alcidion Group Graham Number Historical Data
* Premium members only.
The historical data trend for Alcidion Group's Graham Number can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:ALC vs VEEV, BTSG, TEM: Graham Number Comparison
For the Health Information Services subindustry, Alcidion Group's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alcidion Group Price-to-Graham-Number vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alcidion Group's Price-to-Graham-Number distribution charts can be found below:
* The bar in red indicates where Alcidion Group's Price-to-Graham-Number falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alcidion Group (ASX:ALC) has a Graham Number of A$0.01 as of Dec. 2025. The Graham Number values a company based on its per-share earnings and book value. View historical data on Alcidion Group and its competitors. This is 100% below median its historical median of 10.50. Over the past decade, Alcidion Group's Graham Number has ranged from 10.00 to 10.50. According to the industry distribution chart, Alcidion Group ranks #999999 out of 369 companies in the Healthcare Providers & Services industry.
Is Alcidion Group's Graham Number too high?
Alcidion Group's current Graham Number of A$0.01 is 100% below median its 10-year median of 10.50. Over the past 10 years, this metric has ranged from a low of 10.00 to a high of 10.50. Based on the distribution chart, Alcidion Group ranks #999999 out of 369 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Alcidion Group's Graham Number compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Alcidion Group ranks #999999 out of 369 companies for Graham Number. This places Alcidion Group in the lower half of its industry. The industry median Graham Number is 1.69. Historically, Alcidion Group's own Graham Number has ranged from 10.00 to 10.50 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Healthcare Providers & Services company?
The median Graham Number among Healthcare Providers & Services companies is 1.69, based on 369 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on Alcidion Group and its competitors. For the Healthcare Providers & Services industry, the median Graham Number is 1.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcidion Group's current Graham Number is A$0.01, which is 100% below median its own 10-year median of 10.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcidion Group stock overvalued right now?
Based on GuruFocus' analysis, Alcidion Group (ASX:ALC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.12, compared to a current price of A$0.10 — trading 18.3% below its estimated fair value. The current Graham Number is A$0.01, which is 100% below median its 10-year median of 10.50. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For Alcidion Group (ASX:ALC), the current Graham Number is A$0.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alcidion Group Ltd is a provider of intelligent informatics software. It offers a fully integrated digital patient care platform that includes a clinical decision support (CDS) system, Electronic Patient Record (EPR), and Patient Administration System (PAS). Alcidion is engaged in the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of healthcare software products from its strategic partners, and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in the United Kingdom, Australia, and New Zealand. The company generates maximum revenue from the United Kingdom.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ALC has been successfully added to your 